AnaptysBio
(NASDAQ) ANAB
AnaptysBio Financials at a Glance
Market Cap
$1.99BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$232.39M
Net Income (TTM)
-$26.79M
EPS (TTM)
-$1.08
P/E Ratio
-62.32
Dividend
$0.00
Beta (Volatility)
0.88 (Low)
Dividend
$0.00
Beta (Volatility)
0.88 (Low)
Price
$65.24
Volume
25,661
Open
$66.42
Price
$65.24
Volume
25,661
Open
$66.42
Previous Close
$65.24
Daily Range
$63.65 - $68.37
52-Week Range
$11.40 - $72.36
Estimated Earnings Date
Aug 5, 2026
Dividend
$0.00
Beta (Volatility)
0.88 (Low)
Price
$65.24
Volume
25,661
Open
$66.42
Previous Close
$65.24
Daily Range
$63.65 - $68.37
52-Week Range
$11.40 - $72.36
Estimated Earnings Date
Aug 5, 2026
ANAB News
Why AnaptysBio Plummeted Today
ANAB: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout AnaptysBio
Industry
Biotechnology
Sector
Health CareEmployees
104
CEO
Daniel R. Faga, MBA
Website
www.anaptysbio.comHeadquarters
San Diego, CA 92121-5801, US
ANAB Financials
Key Financial Metrics (TTM)
Gross Margin
116.42%
Operating Margin
17.56%
Net Income Margin
-11.53%
Return on Equity
442.91%
Return on Capital
93.32%
Return on Assets
-8.13%
Earnings Yield
-1.60%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.99BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
29.61M
Volume
25.66K
Avg. Volume
643.31K
Financials (TTM)
Gross Profit
$270.54M
Operating Income
$40.80M
EBITDA
$58.49M
Operating Cash Flow
$4.48M
Capital Expenditure
-$69.00K
Free Cash Flow
$4.41M
Cash & ST Invst.
$286.46M
Total Debt
$277.36M
AnaptysBio Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$25.56M
-8.0%
Gross Profit
$24.95M
+286.0%
Gross Margin
97.61%
N/A
Market Cap
$1.99BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$19.17M
N/A
Employees
104
N/A
Net Income
-$52.88M
-34.5%
EBITDA
-$31.38M
-52.2%
Quarterly Fundamentals
Total Cash
$286.46M
-15.7%
Total Debt
$277.36M
+1680.8%
Accounts Receivable
$25.75M
+44.0%
Inventory
$0.00
N/A
Long Term Debt
$275.24M
+1921.9%
Short Term Debt
$2.12M
+8.1%
Return on Assets
-8.13%
N/A
Return on Invested Capital
14.17%
N/A
Free Cash Flow
-$25.94M
-141.6%
Operating Cash Flow
-$25.92M
-142.2%